WATKINS & EAGER PLLC for ZYNERBA PHARMACEUTICALS, INC.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Government Issues GOV
Brief key House & Senate Members and/or appropriate staff on need and justification for this product. Secure letter of support for applications from key House & Senate Members.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGG L HARPER | Former Member of U.S. House of Representatives |
Health Issues HCR
Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGG L HARPER | Former Member of U.S. House of Representatives |
Pharmacy PHA
Support Zynerba and its partners, and any other of its contractors in its process before the FDA; Troubleshoot inevitable issues and eligibility hurdles to ensure the project is considered for approval; Brief staff of FDA throughout process to ensure they have all information needed; Work with Zynerba to formulate the best strategy to work with FDA in preparation for any scheduled meetings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGG L HARPER | Former Member of U.S. House of Representatives |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.